International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the  Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing more...


  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 181

PDF Downloaded: 218


Sen, Pinnelli, Silvia C R, and Priyanka A: Cognizance of stem cells: A gist


Introduction

Stem cells are undifferentiated cells that are present within the embryonic, fetal, and adult stages of life and gives rise to differentiated cells that are building blocks of tissue and organs.1 The key characteristics feature of stem cells are: (a) self-renewal or the ability to extensively proliferate, (b) clonality which means that it usually arising from one cell, and (c) potency that is the ability to differentiate into different cell types. These properties may differ between various stem cells. For instance, embryonic stem cells (ESCs) derived from the blastocyst have a greater ability for self-renewal and potency while stem cells derived from the adult tissue have limited self-renewal capacity since they might not proliferate extensively and may only differentiate into tissue specific cells. The term stem cells was proposed by Valentine Hacker in 1968. There was a huge contribution by two Russian scientists - Alexander Maximov who proposed the existence of stem cells in the blood and Alexander Friedenstein who isolated the cells from the bone marrow and proposed that these cells can undergo differentiation into bone, cartilage and adipose tissue.2 These cells were later called as mesenchymal stem cells (MSCs). There are two types of stem cells in the bone marrow: hematopoietic stem cells which has the ability to differentiate into various blood cells and mesenchymal stem cells (MSCs). Under no conditions these MSCs differentiate into blood cells despite the fact that MSCs belongs to the hematopoietic stroma. All stem cells incorporates a set of micro environmental factors referred to as “niche” that provides each the resting state of a stem cells and its mobilisation state needed for differentiation or division. Naturally, the cells that has the capability to differentiate into all sorts of adult tissues has a very short lifetime which is throughout the embryogenesis till the gastrula stage. They can be cultivated in vitro (embryonic stem cells) or obtained from differentiated cells by introducing four reprogramming transcription factors – Oct3/4, Sox2, Klf4, and cMyc (induced pluripotent stem cells). Cells derived from the inner cell mass of blastocyst is cultured in vitro and are termed as embryonic stem cells (ESCs). Differentiated derivatives of ESCs have lot of therapeutic applications such as insulin producing cells, retinal pigment epithelium, neurons etc. Japanese scientists Takahashi and Yamanaka have used a technology, so that somatic cells are genetically reprogrammed into pluripotent state. This technology was developed in 2006 by which induced pluripotent stem cells (iPSCs) is obtained from the somatic cells of adults under laboratory conditions.3 For instance, neural cells is created from iPSCs (Figure 5). Induced pluripotent stem cells (iPSCs) is cultured and can be grown unlimited, they additionally undergoes differentiation into each cell kind. iPSCs have already become a vital tool for modeling and learning human diseases, likewise as for drug screening. Cells differentiated from iPSCs potentially is used for replacement therapy in the treatment of diabetes, retinal degeneration, neurodegenerative pathologies, etc.

Figure 1

Stem cells have the ability to (a) Self renew i.e it can create more stem cells indefinitely and (b) Differentiate into (become) specialized, mature cell types

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/3e4020d7-8d14-4e69-9bfe-06d27b110e2a/image/845c918e-9ae4-4b32-ba7f-4b7feabba9da-uimage.png

Stem Cell Niche

In-vivo stem cell phenotype is mostly maintained because of its surrounding microenvironment or niche. This microenvironment is composed of cytokines, proteins, extracellular matrix, basement membrane. All these factors regulates the balance between differentiation and self-renewal of a stem cell. Hackney elucidated the genetic factors that maintains the balance between self-renewal and differentiation.4 The stem cell niche provides an environment that maintains cells in an undifferentiated stem cell state. When there is a local injury in the surrounding tissue morphogenic signals are released which invokes differentiation and proliferation events within the stem cell niche. With the help of stem cell’s intrinsic mechanisms a switch occurs from self-renewal (symmetric division) event to differentiation event (asymmetric division) ; thus mature stem cells are produced. Stem cell differentiation produces a mature cell also called progenitor cell and an addition stem cell. These progenitor cells further undergoes cell division to form fully differentiated cell with specific characteristics and function. Asymmetrical cell divisions maintains the stem cell pool by contributing mature differentiated cells for tissue growth, turnover, or repair. Symmetrical cell divisions maintains the increase or decrease in the stem cell pool by producing either two identical stem cells or two progenitor stem cells. Stem cells such as germ cells, HSC, cancer stem cells maintains their stem cell pool by utilising high telomerase activity without reaching replicative senescence.5 Telomeres are the terminal ends of the eukaryotic chromosomes. It’s primary role is to protect the chromosome from degradation; absence of telomerase activity results in shortening of chromosome until a threshold senescence limit is reached. Cells will be subjected to age dependent mortality, their replicative potential will be reduced and the cells cannot divide. On the other hand, theoretically it has been said that embryonic stem cells produces enough telomerase that their telomeres never get shorten. They are immortal.6

Embryonic State

Embryonic stem cells

Embryonic stem cells were first derived from mouse in 1981.7 But a new era of stem cell biology began with the discovery of human embryonic stem cells in 1988. Zygote is formed after the fertilisation of sperm and ovum. Soon it develops into 8 cell stage known as the blastocyst. Blastocysts are composed of outer trophectoderm (TE) and the inner cell mass (ICM). TE forms the extra embryonic structure to support the developing embryo such as placenta whereas, ICM develops into epiblast and induces the development of a foetus. The cells from ICM is highly proliferative, pluripotent and remains undifferentiated. Human embryonic stem cells (hESCs) are isolated from the inner cell mass. During embryogenesis the cells divide into three germ layers: endoderm, mesoderm and ectoderm. Once they differentiate into one of the germ layers their potency becomes limited to the cells of the germ layers, in short they becomes multipotent stem cells.

Figure 2

Embryonic stem cells are isolated from cells in a blastocyst, a very early stage embryo. Once isolated from the blastocyst, these cells form colonies in culture (closely packed groups of cells). These cells are pluripotent, meaning they can differentiate into cells from all three germ layers (Mesoderm, Ectoderm and Endoderm) which later make up the adult body

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/3e4020d7-8d14-4e69-9bfe-06d27b110e2a/image/06e0dc44-f8db-472d-a6b3-a911fd596042-uimage.png

Umbilical cord blood stem cells

After birth the umbilical cord and Placenta are generally discarded. The blood from the placenta and umbilical cord are rich in hematopoietic stem cells and it was recognised in 1980.8 Advantages of cord blood stem cells includes (a) it has unlimited source of stem cells that can be collected after every birth (b) its collection does not have any risk to mother or child since it is a non invasive procedure (c) the risk of infection is very low9 (d) when stored in liquid nitrogen it is biologically stable therefore cord blood is relatively simple to store and process.

Amniotic fluid-derived stem cells

These are multipotent, undifferentiated cells isolated from the amniotic fluid during the development of the embryo and expresses quite a range of embryonic stem cell markers. In vivo these cells were found to form teratomas and has the ability to form osteogenic, myogenic, adipogenic, neuronal, endothelial and hepatic cells. These cells shows characteristics of both embryonic and non - embryonic stem cells. Amniotic epithelial cells (AECs) are isolated from the amniotic membrane and expresses markers such as Nano, Oct-4 and alkaline phosphatase.10 In addition, these cells has the ability to differentiate into Embryonic stem cells and Embryonic germ cells. When the cells are transplanted into immunodeficient mouse they can proliferate rapidly without loss of its pluripotent potential. Amniotic fluid stem cells is regarded to be the safest alternative to human embryonic stem cells.11

Figure 3

Ectoderm: this is the outer layer of cells in the embryo and it will develop into skin, the nervous system, sensory organs, tooth enamel, eye lens, and other structures. Mesoderm: this is the middle layer of cells in the embryo and it will develop intomuscle, bone, blood, kidneys, connective tissue, and related structures. Endoderm: this is the inner layer of cells in the embryo and it will develop into lungs, digestive organs, the liver, the pancreas, and other organs

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/3e4020d7-8d14-4e69-9bfe-06d27b110e2a/image/7b40844c-3ae8-4530-ab83-32f381362511-uimage.png

Non-embryonic State

Adult stem cells (ASC) or somatic stem cells are undifferentiated cells found among the differentiated cells in the human body after development. They play an important role in growth, repair and replacement of cells that are lost everyday.12 Adult stem cells comprises of (a) Mesenchymal stem cells (MSC) - These cells are present in various tissues including bone marrow.13 The cells from the bone marrow mainly differentiate into fat cells, bone and cartilage. (b) Neural stem cells (NCS) - gives rise to nerve cells and other cell types such as astrocytes and oligodendrocytes (c) Skin stem cells - gives rise to keratinocytes which acts as a protective layer of skin (d) Haematopoietic stem cells – give rise to all kinds of blood cells such as Red blood cell, White blood cells and platelets. They have a restricted differentiation option and a longer proliferation time than embryonic stem cells (ESCs). Adult stem cells can be reprogrammed back to their pluripotent state and this can be done by transferring adult nucleus into the cytoplasm of a oocyte or by fusing with a pluripotent cell. This technique was performed while cloning the famous sheep Dolly.14

Figure 4

Adult stem cells or Somatic Stem Cell are the cells that are harvested from tissues in an adult body. These cells are usually multipotent, that means they can differentiate into cells from some, but not all, of the three germ layers. They are thought to act to repair and regenerate the tissue in which they are found in, but usually they can differentiate into cells of completely different tissue types

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/3e4020d7-8d14-4e69-9bfe-06d27b110e2a/image/6cdf76f3-0f7c-450c-9c24-c301a5b025d7-uimage.png

Bone marrow stem cells

Bone marrow stem cells (BMCs) are of two types (a) Bone Marrow Hematopoietic Stem Cells, which constitutes only 0.05% of whole bone marrow, has the ability to form all blood lineages including erythrocytes, leukocytes, and platelets. Since they have a unique morphology, with the help of labeled cell surface markers they can be easily tracked in the blood.15 (b) Bone Marrow Stromal Stem Cells (BMSCs). The storma of the bone marrow is a heterogeneous population of connective tissue, which constitutes the niche of haematopoietic stem cells and supports bone marrow hematopoiesis. BMSCs can be isolated and cultured from the bone marrow after density gradient centrifugation. The mono nuclear cells isolated can be cultured in DMEM or alpha MEM media supplied with 10-15% fetal calf serum. BMSCs has the ability to get attached to the plastic dish used in cell and tissue culture laboratory, leaving behind adherent fibroblast-like cells. These cells has the capability to proliferate rapidly. Haematopoietic stem cells has been studied experimentally for 50 years and its the best characterized stem cell niche.11 One of the most popular stem cell therapy is haematopoietic stem cell transplantation with a significantly high success rate and they have a great potential in regenerative medicine. Multipotent HSCs can be isolated from peripheral blood, umbilical cord blood and bone marrow, using autologous, allogenic or syngeneic procedure all the functional haematopoietic lineages in blood can be generated. Thus, leukaemia and anaemia which are due to poor haematopoietic system functioning can be treated with Haematopoietic stem cell transplantation.

Mesenchymal stem cells

Multipotent Mesenchymal stem cells (MSCs) are derived from various tissues such as skin, fat and bone marrow. It is reported that bone marrow and gingival tissue are the primary source of Mesenchymal stem cells.16 Human adult MSCs are isolated from non hematopoietic tissues, for example, trabecular bone,17 dental pulp,18 synovium,19 adipose tissue,20 dermis,21 lung.22 The cells appears fibroblastic, have the ability to differentiate into multiple cell lineages and the cells can undergo many passages. Since the MSCs population is strongly adherent, they can be easily cultured on a appropriate substrate and wash other cells off. Dennis and Caplan, 2004 reported that Mesenchymal stem cells are essential to maintain the microenvironment which is required to support the hematopoietic stem cells in the bone marrow.23 In vitro, MSC culture expresses certain surface markers, some of the positive markers include b-1-integrin, CD29, CD44, CD90, CD105, CD73 and shows negative expression of hematopoietic markers i.e, CD34, CD14, and CD45. Mesenchymal stem cells when cultured in vitro differentiate primarily into mesenchyme lineage - adipose tissue, bone and cartilage.24, 16

Pancreatic stem cells

The adult pancreas has three types of tissue - the exocrine acini which secretes digestive enzymes, the ductal tree and the endocrine islets of Langerhans. There are five types of cells in the islets of Langerhans which includes alpha cell producing glucagon, beta cell producing insulin, delta cells secretes somatostatin, PP cells produces pancreatic polypeptide and epsilon cells secretes ghrelin. The ducts and the islets of the adult human pancreases contains multipotent cell progenitors.25, 26 The multipotent Pancreatic stem cells has been reported to be isolated from human fetal pancreas which expresses certain stem cell markers. When these cells are cultured ex vivo islet like cell clusters (ICCs) are formed which in turn can give rise to various pancreatic cell lineages such as insulin secreting alpha cells.27 Type 1 diabetes which is due to autoimmune destruction of cells in the islets of pancreas can be reversed by islet cell transplantation.

Figure 5

The use of pluripotent stem cells for engineering neural tissue

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/3e4020d7-8d14-4e69-9bfe-06d27b110e2a/image/dc150f4f-834f-4b8e-a3be-3ebda2aa3587-uimage.png

Skin stem cells

The largest organ in the human body i.e the skin is derived from ectoderm germ layer during the process of embryogenesis. Multipotent stem cells were isolated from the dermis as reported in 2001, these cells can be cultured and it undergoes differentiation and proliferation to form mesodermal cells as well as neural cells. Previous studies have proved that the upper region of hair follicles and the bulge area is the niche for multipotent stem cells. They play an important role in epidermal regeneration after tissue injury and also responsible for long term hair follicle growth. To be more specific, multipotent epithelial stem cells (bESCs) which are present within the bulge area, expresses certain markers such as CD34, K5, 6 integrin which can proliferate to form follicular epithelium. The bulge area of the hair follicle also contains pluripotent epidermal neural crest stem cell (eNCSC) which has the property similar to embryonic neural crest stem cells, they undergoes self renewal and produces multiple cells such as neurons, Schwann cells, chondrocytes, melanocytes and smooth muscle cells.28

Neural stem cells

Neural stem cells (NSC) are multipotent cells which has continuous self-renewal capacity, can be isolated from the brain of embryos and adult and has the ability to generate cells of both neural and glial lineage.29, 30 When NSCs are cultured in vitro they cluster to form neurospheres and undergoes differentiation to form neuroectodermal lineages.31 It was reported that when these neural stem cells injected into blastocysts of a mice they give rise to multiple types of tissues.32 Adult neural stem cells differentiate to form multiple type of cells including neurones, astrocytes, oligodendrocytes thus providing a therapeutic advantage for Parkinson's disease as these cells can be used as transplants.

Application of Stem Cells in Major Diseases

Neurological disorders

Central nervous system (CNS) when matured, its self repair capacity decreases thus scientist are finding out new cell-engineering techniques to regenerate neurons which are damaged. Parkinson’s and Alzheimer’s are the most common neurodegenerative disorders with the advancement of age. In neurodegenerative disorders physiologically active neurons are lost over a period of time leading to morbidity and mortality.33 Cell replacement therapy is one of the most common application of stem cells in Central nervous system disorders. With the help of this therapy there will be inexhaustible source of neurons which can be implanted to replace the damaged cells in Alzheimer’s, Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis.34, 35, 29 In Alzheimer’s disease, cognitive ability is hampered due to the damage of cholinergic neurons present in the basal forebrain. To prevent this, scientist have generated cholinergic neurons in vitro from neural stem cells and transplanted these neurons successfully. Lee and his group has converted mouse Embryonic stem cells to dopamine like characteristics cells,36 similarly Kawasaki and his group have produced dopamine neurons without the formation of embroid body.37 However transplantation of dopaminergic neurons shows long lasting improvement in few patients only.38 The biggest limitation is the generation of functional dopamine neurons and the functions of other cell types for instance the glial cells. It is also important to integrate these cells successfully into the brain parenchyma as these cells are extremely site specific. The transplanted cells should have the capability to interlink with the host cells and establish the damaged neural circuit without immune rejection.

Skeletal muscle cells

Although skeletal muscle tissue has the ability to regenerate but it decreases as the age of the patient increases. When the muscle loses its regenerative ability, adipose tissue fills up the defect. Duchenne muscular dystrophy (DMD) is one of the serious diseases due to lack of dystrophin protein resulting in degeneration of the myofibers. Several studies have been carried out, however no therapy is available to prevent muscle deterioration; thus muscle regeneration seems to be an attractive treatment.39, 35 The regenerative capacity of the muscles is due to the presence of satellite cells. These are mononuclear cells which fuse together to form multinucleated myotubes. It is observed that transplanting one myofiber containing as less as seven satellite cells has the ability to give rise to more than hundred new myofibers.40 DMD can affect various muscles in a multifocal manner therefore treating such damaged muscles using local implantation method becomes extremely challenging.41 With the improvement of intra arterial and systemic cell delivery techniques this challenge can be addressed.

Bone disorders

Several molecular mechanisms has been established from stem cells for bone repair. One such advancement in replacing musculoskeletal tissues is manufacturing of scaffolds.35 Several studies have shown that cells of ligament and tendon has multilineage differentiation potential. Lee and his group has observed that cells from synovial fluid has the capability to differentiate into chondrocytes, osteoblasts and adipocytes.36 Cells from tendon also has the potential of multilineage differentiation. Stem cells have been extensively studied in meniscal healing by injecting synovium derived stem cells labelled with fluorescent protein in the knees of wild type rats which has defect in the meniscus.42 Regeneration of bone is a complex process, there should be a well coordination between systemic and local soluble factors, endothelial progenitors, Bone marrow mesenchymal stem cells and extracellular matrix. Several studies demonstrated that bone marrow mesenchymal stem cells has the ability to expand ex vivo and can repair critical bone defects.

Cardiac disease

It has been estimated that approximately 16.7 million people die due to cardiovascular disease (WHO, 2006). The ultimate goal of stem cell therapy is to replace the damaged cardiovascular function. Various cell types required for properly functioning heart include Cardiomyocytes, vascular endothelial cell and smooth muscle cell. Recent studies have shown that embryonic and adult stem cells has the potential capability to develop into these cell types, establish new blood vessel and restore the damaged cardiac muscle. With such strategy patients with congestive heart failure and heart attacks can be treated. cardiomyocytes have been derived from human embryonic stem cells when engrafted in several rodent models; improvement in cardiac function was noticed.43 Studies have demonstrated that adult bone marrow stem cells have the capacity to give rise to endothelial cells, smooth muscle cells and myocytes in ischemic myocardium. Cardiac stem cells are undifferentiated cells recognised in many laboratories. Cardiac progenitor cells when cultured in vitro are multipotent while in vivo they give rise to cardiomyocytes and coronary vessels.44 Messina identified clusters of self-adherent cells knows as cardiospheres that grew from adult cardiac tissue culture derived from murine and human hearts.45 These cells have the properties of inducing myocardial and vascular regeneration after Myocardial Infarction. Smith and his group have demonstrated that these cardiospheres can be grown from human endomyocardial biopsy specimens.46 Another population of stem cells known as unrestricted somatic stem cells derived from human umbilical cord blood stem cells when injected directly at thoracotomy immunosuppressed pigs after MI has minimised infarct scar size, enhanced perfusion, wall motion and cardiac function.47 However, there are no clinical trials of human cardiac stem cells till date.

Cancer

To arrest the growth of cancer cell various studies have been carried out with several cancer cell line in vivo and in vitro. Cancer cells cause damage to hematopoietic cells and other normal tissues.48, 49 Patients receiving high doses of chemotherapeutic agents causes severe damage to the blood forming cells. The Hematopoietic stem cells from the bone marrow can be mobilised into the peripheral blood using AMD3100, G-CSF etc. These are the mobilizing agents which leads to the expansion of stem cells and their progenitors in bloodstream therefore the recovery time can be reduced after High-Dose Chemotherapy. Leukaemia stem cells also has the self renewal capacity and has specific phenotype such as CD123+ CD90-, CD117- thus maintaining the leukemic blasts.50 Umbilical cord blood has CD16-/CD56+ natural killer cells. It shows high proliferation rate and cytotoxic effects against some cancers. These cells can be expanded in the presence of IL-12 or IL-15.51 Dendritic cells derived from the Hematopoietic stem cells can be used as alternative treatment in cancer immunotherapy in order to replace the neoplastic cells. Stem cell transplants can be the promising therapy where the endogenous stem cells can be replaced with the new cells thus producing healthy hematopoietic cell lineages and immune defense system can be repaired.

Diabetes

With the technological advancements scientists have made considerable effort to restore the function of b cells or to generate surrogate b cells from various types of stem cells such as Adult stem cells, Embryonic stem cells for the treatment of Diabetes. Treatment using ESCs has not been approved yet therefore Adult stem cell is fairly used in research and medical practice.52, 53 Human pancreatic islets contains potential pancreatic stem cells; minute amount of pancreatic tissue has the ability to restore the maximum pancreatic b-cell mass. This might be due to the differentiation of b-cells and de differentiated b-cells produces pluripotent cells which in turn results in the production of more b-cells.54, 55 Studies have shown that in vitro adult pancreatic precursor cells can produce insulin and C-peptide.56 It has been clearly established that insulin producing cells can be produced from stem cells however there are certain disadvantages such as teratoma formation, autoimmune response, transplantation issues which needs to be further explored. Various factors and pathways regulates the development of b cells, studies must be conducted to understand these pathways in order to find cure towards diabetes.57 More research strategies are needed to activate pancreatic stem cells in the patients with diabetes to induce b-cell formation. Further research need to be conducted to isolate and expand these stem cells ex vivo for transplantation.

Conclusion

The stem cell concept developed in nineteenth century by some researchers who were working on the embryonic development. They proposed that these cells act as a starting point for the biological processes. During second world war the knowledge of stem cells advanced with the identification of a recovery factory in bone marrow which could regenerate the blood system. It was during this time stem cells were first used for bone marrow transplants for the treating cancer and other blood disorders. At present, there is a increasingly use of stem cells and every year 60,000 bone marrow operations are being conducted worldwide. Stem cells can not only be used in bone marrow transplants; the physicians are able to regenerate damaged tissue and develop new therapies in the field of regenerative medicine. Mechanism of cell signalling and cell differentiation can be understood with stem cells thus the underlying cause of the disease can be studied. Since stem cells can differentiate into large number of specialised cells it is used to test the safety of new medicines and therefore animal testing can be avoided. Today, many clinical studies have been conducted for the treatment of heart disease, retinal diseases, diabetes and neurological conditions. Use of stem cells have already being approved in south Korea and Canada for the treatment of osteoarthritis and myocardial infarction. Since 2008, eight successful patients have received trachea transplants. The tracheas were artificially created in the laboratory by growing the patients stem cells on a scaffold. Such approach can be used in future for creating other organs such as lungs, kidney, heart valve etc. In 1981, scientists first isolated embryonic stem cells from mice blastocysts. Embryonic stem cells are extensively used to treat models of diabetes, parkinson’s disease, myocardial infarction, spinal injury, and a severe genetic immune disorder. Embryonic stem (ES) cells are pluripotent and can differentiate into all three embryonic germ layers; because of this characteristics they are greatly used in transplantation therapies.

Source of Funding

None.

Conflict of Interest

The authors declare that there is no conflict of interest.

References

1 

M Ramalho-Santos H Willenbring On the Origin of the Term “Stem Cell”Cell Stem Cell20071135810.1016/j.stem.2007.05.013

2 

H Abrahamse Regenerative Medicine, Stem Cells, and Low-Level Laser Therapy: Future DirectivesPhotomed Laser Surg201230681210.1089/pho.2012.9881

3 

K Takahashi S Yamanaka Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell20061266637610.1016/j.cell.2006.07.024

4 

CE Burns LI Zon Portrait of a Stem CellDev Cell200235612310.1016/s1534-5807(02)00329-5

5 

SJ Morrison AM Wandycz K Akashi A Globerson IL Weissman The aging of hematopoietic stem cellsNat Med1996291011610.1038/nm0996-1011

6 

JJ Buzzard NM Gough J M Crook A Colman Karyotype of human ES cells during extended cultureNat Biotechnol2004224381210.1038/nbt0404-381

7 

MJ Evans MH Kaufman Establishment in culture of pluripotential cells from mouse embryosNature1981292154610.1038/292154a0

8 

LP Koh NJ Chao Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimensBiol Blood Marrow Transplant200410112210.1016/j.bbmt.2003.09.009

9 

P Hollands Cord blood stem cells-the basic scienceFrontiers of Cord Blood ScienceSpringerLondon20091925

10 

V Ramakrishna PB Janardhan L Sudarsanareddy Stem cells and regenerative medicine-A reviewAnn Res Rev Biol201179110

11 

H Abdelkrim DB Juan W Jane A Mohamed S Bernat The immune boundaries for stem cell based therapies: problems and prospective solutionsJ Cell Mol Med2009138a14647510.1111/j.1582-4934.2009.00837.x

12 

M Rumman J Dhawan M Kassem Concise Review: Quiescence in Adult Stem Cells: Biological Significance and Relevance to Tissue RegenerationStem Cells2015331029031210.1002/stem.2056

13 

G Chamberlain J Fox B Ashton J Middleton Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingStem Cells2007251127394910.1634/stemcells.2007-0197

14 

AL Bonnicksen Crafting a cloning policy: from Dolly to stem cellsGeorgetown University Press2002

15 

E Lagasse H Connors M Al-Dhalimy M Reitsma M Dohse L Osborne Purified hematopoietic stem cells can differentiate into hepatocytes in vivoNat Med200061112293410.1038/81326

16 

GB Tomar RK Srivastava N Gupta AP Barhanpurkar ST Pote HM Jhaveri Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicineBiochem Biophys Res Commun201039333778310.1016/j.bbrc.2010.01.126

17 

U Nöth R Tuli AM Osyczka KG Danielson RS Tuan In Vitro Engineered Cartilage Constructs Produced by Press-Coating Biodegradable Polymer with Human Mesenchymal Stem CellsTissue Eng2002811314410.1089/107632702753503126

18 

L Pierdomenico L Bonsi M Calvitti D Rondelli M Arpinati G Chirumbolo Multipotent Mesenchymal Stem Cells with Immunosuppressive Activity Can Be Easily Isolated from Dental PulpTransplantation20058068364210.1097/01.tp.0000173794.72151.88

19 

C De Bari F Dell'Accio P Tylzanowski FP Luyten Multipotent mesenchymal stem cells from adult human synovial membraneArthritis Rheumatism200144819284210.1002/1529-0131(200108)44:8<1928::aid-art331>3.0.co;2-p

20 

PA Zuk The Adipose-derived Stem Cell: Looking Back and Looking AheadMol Biol Cell201021111783710.1091/mbc.e09-07-0589

21 

HE Young TA Steele RA Bray J Hudson JA Floyd K Hawkins Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donorsAnatomical Rec20012641516210.1002/ar.1128

22 

F Sabatini L Petecchia M Tavian VJ Villeroché GA Rossi D Brouty-Boyé Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialitiesLab Investig20058589627110.1038/labinvest.3700300

23 

JE Dennis AI Caplan Bone marrow mesenchymal stem cellsStem cells handbookHumana PressTotowa, NJ200410717

24 

JM Fox G Chamberlain BA Ashton J Middleton Recent advances into the understanding of mesenchymal stem cell traffickingBr J Haematol2007137649150210.1111/j.1365-2141.2007.06610.x

25 

RM Seaberg SR Smukler TJ Kieffer G Enikolopov Z Asghar MB Wheeler Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineagesNat Biotechnol200422911152410.1038/nbt1004

26 

L Bouwens I Rooman Regulation of Pancreatic Beta-Cell MassPhysiol Rev200585412557010.1152/physrev.00025.2004

27 

PM Suen PS Leung Pancreatic stem cells: a glimmer of hope for diabetes?JOP2005654224

28 

JG Toma M Akhavan KJL Fernandes F Barnabé-Heider A Sadikot DR Kaplan Isolation of multipotent adult stem cells from the dermis of mammalian skinNat Cell Biol2001397788410.1038/ncb0901-778

29 

JM Baizabal M Furlan-Magaril J Santa-Olalla L Covarrubias Neural stem cells in development and regenerative medicineArch Med Res20033465728810.1016/j.arcmed.2003.09.002

30 

FH Gage Mammalian neural stem cellsScience2000287545714338

31 

AC Brignier AM Gewirtz Embryonic and adult stem cell therapyJ Allergy Clin Immunol20101252S3364410.1016/j.jaci.2009.09.032

32 

DL Clarke B Clas J Johansson B Wilbertz E Veress H Nilsson Generalized potential of adult neural stem cellsScience2000288547116603

33 

B Steiner SA Wolf G Kempermann Adult neurogenesis and neurodegenerative diseaseRegen Med20061152810.2217/17460751.1.1.15

34 

WMADB Fernando G Somaratne KG Goozee S Williams H Singh RN Martins Diabetes and Alzheimer’s Disease: Can Tea Phytochemicals Play a Role in Prevention?J Alzheimers Dis201759248150110.3233/jad-161200

35 

D Sheyn O Mizrahi S Benjamin Z Gazit G Pelled D Gazit Genetically modified cells in regenerative medicine and tissue engineering☆Adv Drug Deliv Rev2010627-86839810.1016/j.addr.2010.01.002

36 

CY Lee BD Wilkinson SE Siegrist RP Wharton CQ Doe Brat Is a Miranda Cargo Protein that Promotes Neuronal Differentiation and Inhibits Neuroblast Self-RenewalDev Cell2006104441910.1016/j.devcel.2006.01.017

37 

H Kawasaki K Mizuseki S Nishikawa S Kaneko Y Kuwana S Nakanishi Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing ActivityNeuron200028314010.1016/s0896-6273(00)00083-0

38 

O Lindvall Z Kokaia A Martinez-Serrano Stem cell therapy for human neurodegenerative disorders–how to make it workNat Med200410S7S42S5010.1038/nm1064

39 

TAH Järvinen TLN Järvinen M Kääriäinen V Äärimaa S Vaittinen H Kalimo Muscle injuries: optimising recoveryBest Pract Res Clin Rheumatol20072123173110.1016/j.berh.2006.12.004

40 

CA Collins I Olsen PS Zammit L Heslop A Petrie TA Partridge Stem Cell Function, Self-Renewal, and Behavioral Heterogeneity of Cells from the Adult Muscle Satellite Cell NicheCell2005122228930110.1016/j.cell.2005.05.010

41 

R Benchaouir M Meregalli A Farini G D'Antona M Belicchi A Goyenvalle Restoration of Human Dystrophin Following Transplantation of Exon-Skipping-Engineered DMD Patient Stem Cells into Dystrophic MiceCell Stem Cell2007166465710.1016/j.stem.2007.09.016

42 

N Mizuno H Shiba Y Ozeki Y Mouri M Niitani T Inui Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell culturesCell Biol Int2006306521410.1016/j.cellbi.2006.01.010

43 

KR Boheler J Czyz D Tweedie HT Yang SV Anisimov AM Wobus Differentiation of Pluripotent Embryonic Stem Cells Into CardiomyocytesCirc Res200291318920110.1161/01.res.0000027865.61704.32

44 

AP Beltrami L Barlucchi D Torella M Baker F Limana S Chimenti Adult Cardiac Stem Cells Are Multipotent and Support Myocardial RegenerationCell200311467637610.1016/s0092-8674(03)00687-1

45 

E Messina L De Angelis G Frati S Morrone S Chimenti F Fiordaliso Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine HeartCirc Res20049599112110.1161/01.res.0000147315.71699.51

46 

RR Smith L Barile HC Cho MK Leppo JM Hare E Messina Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy SpecimensCirculation2007115789690810.1161/circulationaha.106.655209

47 

BO Kim H Tian K Prasongsukarn J Wu D Angoulvant S Wnendt Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine modelCirculation20051129_supplement96104

48 

P Phatak JC Cookson F Dai V Smith RB Gartenhaus MFG Stevens Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanismBr J Cancer200796812233310.1038/sj.bjc.6603691

49 

PS Knoepfler Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative MedicineStem Cells20092751050610.1002/stem.37

50 

JW Cui XM Zhang GJ Wang Progress in the studies of acute myelogenous leukemia stem cellZhongguo Shi Yan Xue Ye Xue Za Zhi200311554952

51 

Y Cohen A Nagler Umbilical cord blood transplantation – how, when and for whom?Blood Rev20041831677910.1016/s0268-960x(03)00064-x

52 

B Soria E Roche G Berna TL Quinto JA Reig F Martin Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic miceDiabetes20004921576210.2337/diabetes.49.2.157

53 

N Lumelsky Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic IsletsScience2001292552013899410.1126/science.1058866

54 

SB Weir LA Susan GT Baxter FE Smith A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic developmentDiabetes19934212171524

55 

S Bonner-Weir M Taneja GC Weir K Tatarkiewicz KH Song A Sharma In vitro cultivation of human islets from expanded ductal tissueProc Natl Acad Sci200097147999800410.1073/pnas.97.14.7999

56 

RM Seaberg SR Smukler TJ Kieffer G Enikolopov Z Asghar MB Wheeler Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineagesNat Biotechnol200422911152410.1038/nbt1004

57 

X Xu J D'Hoker G Stangé S Bonné N De Leu X Xiao β Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse PancreasCell2008132219720710.1016/j.cell.2007.12.015



jats-html.xsl

© This is an open access article distributed under the terms of the Creative Commons Attribution License - Attribution 4.0 International (CC BY 4.0). which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article type

Review Article


Article page

1-8


Authors Details

Debalina Sen, Venkata Bharat Kumar Pinnelli, Wilma Delphine Silvia C R, Priyanka A


Article History

Received : 15-02-2021

Accepted : 24-03-2021

Available online : 30-04-2021


Article Metrics


View Article As

 


Downlaod Files